Kennedy Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-52,978
Closed -$3.11M – 604
2026
Q2
$3.11M Sell
52,978
-1,342
-2% -$56.3K 0.06% 391
2026
Q1
$1.75M Buy
+54,320
New +$2.01M 0.04% 436

Other funds holding VCYT

Kennedy Capital Management's VCYT Position: Q3 2026 in Review

Kennedy Capital Management sold out of Veracyte (VCYT) in Q3 2026, closing a stake of 52,978 shares — an estimated $3.11M sold.

Kennedy Capital Management first reported a position in VCYT in Q1 2026 and held it in 2 quarters. The position peaked at $3.11M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Kennedy Capital Management reported no remaining Veracyte position as of Q3 2026 after selling out during the quarter.
  • Kennedy Capital Management sold 52,978 Veracyte shares in Q3 2026, an estimated $3.11M.
  • Kennedy Capital Management first reported a position in Veracyte in Q1 2026 and held it in 2 quarters.
  • Kennedy Capital Management's Veracyte position peaked at $3.11M in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.